DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

Saved in:
Bibliographic Details
Title: DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.
Authors: Pecoraro G; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Institute of Oncology Research (IOR), Bellinzona, Switzerland.; Clinical and Translational Oncology, Scuola Superiore Meridionale, Via Mezzocannone 4, 80134, Naples, Italy., De Giorgi A; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Medical Oncology Department, Turin University, Turin, Italy., Montelatici G; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Salfi G; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Lin HM; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Turco F; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Taha T; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., de Bono J; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK.; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Aggarwal RR; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., von Amsberg G; University Cancer Center Hamburg and Martini-Klinik, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Joerger M; Department of Medical Oncology and Hematology, Health Ostschweiz (HOCH), St Gallen, Switzerland., Imbimbo M; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Colombo I; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Gillessen S; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Pedrani M; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland. martino.pedrani@eoc.ch.
Source: Drugs [Drugs] 2026 Jul 29. Date of Electronic Publication: 2026 Jul 29.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first